Cameron Turtle is the founder of Spyre Therapeutics. Spyre Therapeutics has raised $644M in total funding. Latest round: Growth. Based in Cambridge, MA.
Cameron Turtle is the CEO of Spyre Therapeutics, a biotechnology company focused on developing therapeutic combinations for inflammatory bowel disease (IBD). He was appointed CEO in November 2023 when the company renamed from Aeglea BioTherapeutics. Turtle has been involved in significant financing activities for the company, including a $180 million PIPE investment.
Full founder directory · Investor directory · Company funding database · Fundraising library